Hi FlippinPhil listening to both sides pro’s and con’s to vote out the options or vote for them…
From the prospectus detail provided below…
It appears the offer has upset the balance of required funds and unnecessary dilution at mates rates…This imo indicates the broker has not considered the full consequences and likely push back against the options being voted down. I suppose a disappointing aspect of this raise has been the lack of marketing and no news is good news. IMO this is not working and needs to be changed
With the advanced state of Anteo tech battery technology and still no concrete connection to any EV manufacture. “Not one” It was said at the AGM more mongrel yet zero extra details are given. We go into a cash raise and the market expecting news flow received an extension to the prospectus because no mongrel was apparent…The company has great technology great scientists yet no visible evidence of mongrel marketing… None
Marketing was so poor they even required an extension to the offer…should have been closed sooner but rather than news and mongrel marketing it appears someone dumped into the prospectus period and made investors nervous…And now seek a yes on the options available…With possible further grants on the near term horizon and completion of the pilot plant we need a client that is prepared to be named ASAP…
If the science is that good and pack leading as they say it’s good enough to be named along side their brand…Large holders have every reason to be pis#”# at this present time…No mongrel naming and hand out cheap options
Regards Croc
- Forums
- ASX - By Stock
- ADO
- why ADO is a multi multi bagger
why ADO is a multi multi bagger, page-296
-
- There are more pages in this discussion • 2,135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
-0.001(2.33%) |
Mkt cap ! $52.28M |
Open | High | Low | Value | Volume |
2.1¢ | 2.1¢ | 2.1¢ | $2.485K | 118.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 1157654 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 400834 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 1157654 | 0.021 |
11 | 1570501 | 0.020 |
7 | 1069486 | 0.019 |
7 | 2036279 | 0.018 |
3 | 359496 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 400834 | 2 |
0.023 | 649844 | 7 |
0.024 | 991966 | 4 |
0.025 | 1130539 | 12 |
0.026 | 291415 | 3 |
Last trade - 15.46pm 24/09/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online